These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Regulation of TLR expression, a new perspective for the role of VIP in immunity. Gomariz RP; Arranz A; Juarranz Y; Gutierrez-Cañas I; Garcia-Gomez M; Leceta J; Martínez C Peptides; 2007 Sep; 28(9):1825-32. PubMed ID: 17706836 [TBL] [Abstract][Full Text] [Related]
4. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease. Thrane AS; Skehan JD; Thrane PS Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498 [TBL] [Abstract][Full Text] [Related]
5. Immunity to self and self-maintenance: a unified theory of brain pathologies. Schwartz M; Ziv Y Trends Immunol; 2008 May; 29(5):211-9. PubMed ID: 18328784 [TBL] [Abstract][Full Text] [Related]
6. Cell death recognition model for the immune system. Sun E Med Hypotheses; 2008; 70(3):585-96. PubMed ID: 17681705 [TBL] [Abstract][Full Text] [Related]
7. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn. Fleer A; Krediet TG Neonatology; 2007; 92(3):145-57. PubMed ID: 17476116 [TBL] [Abstract][Full Text] [Related]
8. The evolution of mathematical immunology. Louzoun Y Immunol Rev; 2007 Apr; 216():9-20. PubMed ID: 17367331 [TBL] [Abstract][Full Text] [Related]
9. Integrating immunity: the immunculus and self-reactivity. Poletaev AB; Stepanyuk VL; Gershwin ME J Autoimmun; 2008; 30(1-2):68-73. PubMed ID: 18191542 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors and immune regulation: implications for cancer therapy. Wang RF; Miyahara Y; Wang HY Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599 [TBL] [Abstract][Full Text] [Related]
11. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors. Romagne F Drug Discov Today; 2007 Jan; 12(1-2):80-7. PubMed ID: 17198976 [TBL] [Abstract][Full Text] [Related]
12. [From clone selection to danger model]. Huang Y; Zhu LP; Zhang W Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):430-3. PubMed ID: 12905670 [TBL] [Abstract][Full Text] [Related]
13. Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors. Albiger B; Dahlberg S; Henriques-Normark B; Normark S J Intern Med; 2007 Jun; 261(6):511-28. PubMed ID: 17547708 [TBL] [Abstract][Full Text] [Related]
15. Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat. Fritz JH; Le Bourhis L; Magalhaes JG; Philpott DJ Trends Immunol; 2008 Jan; 29(1):41-9. PubMed ID: 18054284 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D and innate immunity. Hewison M Curr Opin Investig Drugs; 2008 May; 9(5):485-90. PubMed ID: 18465658 [TBL] [Abstract][Full Text] [Related]
17. Innate and adaptive immune pathways to tolerance. Thornton CA; Morgan G Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514 [TBL] [Abstract][Full Text] [Related]
18. Impact of innate and adaptive immunity on rejection and tolerance. Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649 [TBL] [Abstract][Full Text] [Related]
19. Current concepts of molecular defence mechanisms operative during urinary tract infection. Weichhart T; Haidinger M; Hörl WH; Säemann MD Eur J Clin Invest; 2008 Oct; 38 Suppl 2():29-38. PubMed ID: 18826479 [TBL] [Abstract][Full Text] [Related]
20. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. Reiling N; Ehlers S; Hölscher C Immunol Lett; 2008 Feb; 116(1):15-23. PubMed ID: 18191460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]